(1)
Blauvelt, A.; Gottlieb, A.; Fierens, F.; Brock, F.; Wiegratz, S.; Sofen, H. Dose Adjustment Patterns in the Open-Label Extension Arms of Three Phase 3 Trials of Certolizumab Pegol in Psoriasis: CIMPASI-1, CIMPASI-2, and CIMPACT. J of Skin 2020, 4, s85.